GW Pharmaceuticals PLC Holding(s) in Company (7127L)
July 08 2014 - 4:18AM
UK Regulatory
TIDMGWP
RNS Number : 7127L
GW Pharmaceuticals PLC
08 July 2014
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
----------------------------------------------------------------------------------------
1. Identity of the issuer or the underlying GW Pharmaceuticals plc
issuer
of existing shares to which voting rights
are
attached:
------------------------------------------------- -------------------------------------
2 Reason for the notification (please tick the appropriate box or boxes):
----------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
------------------------------------------------------------------------------- -------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
------------------------------------------------------------------------------- -------
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
------------------------------------------------------------------------------- -------
An event changing the breakdown of voting rights
------------------------------------------------------------------------------- -------
Other (please
specify):
------------------ ----------------------------------------------------------- -------
3. Full name of person(s) subject The Capital Group Companies, Inc.
to the
notification obligation:
------------------------------------------ --------------------------------------------
4. Full name of shareholder(s) Capital Research and Management Company
(if different from 3.):
------------------------------------------ --------------------------------------------
5. Date of the transaction and date 3 July 2014
on
which the threshold is crossed
or
reached:
------------------------------------------ --------------------------------------------
6. Date on which issuer notified: 7 July 2014
------------------------------------------ --------------------------------------------
7. Threshold(s) that is/are crossed Above 10%
or
reached:
------------------------------------------ --------------------------------------------
8. Notified details:
------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN CODE
--------------- ------------------------------------ -----------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of rights
Shares Voting shares
Rights
--------------- -------------- -------------------- --------- ----------------------- -----------------------------
Direct Direct Indirect Direct Indirect
--------------- ---- ------ ------ ----- ----- --------- ---------- ----------- --------------- ------------
ADRs
(US36197T1034) 1,947,957 23,375,484 23,855,484 10.111%
--------------- -------------- -------------------- --------- ---------- ----------- --------------- ------------
B: Qualifying Financial Instruments
------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion Period rights that may rights
be
acquired if the
instrument is
exercised/ converted.
----------------------- -------------- ----------------------------- ---------------------------- ------------------
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments (xv, xvi)
------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting rights
financial price date Conversion rights instrument
instrument period refers to
----------------- ------------ ------------- ---------------- ---------------------------- ------------------------
Nominal Delta
----------------- ------------ ------------- ---------------- ---------------------------- ------------- ---------
Total (A+B+C)
------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------------------- ---------------------------------------------------------
23,855,484 10.111%
------------------------------------------------------------- ---------------------------------------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable:
--------------------------------------------------------------------------------
Holdings by Capital Research and Management Company SMALLCAP World Fund,
Inc
Proxy Voting:
--------------------------------------------------------------------------------
10. Name of the proxy holder:
--------------------------------------------------- ---------------------------
11. Number of voting rights proxy holder will
cease
to hold:
--------------------------------------------------- ---------------------------
12. Date on which proxy holder will cease to
hold
voting rights:
--------------------------------------------------- ---------------------------
13. Additional information:
---------------------------------------- --------------------------------------
14. Contact name: Christopher Aquino
---------------------------------------- --------------------------------------
15. Contact telephone number: 800-421-8511
---------------------------------------- --------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEANXPEFXLEEF
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about GW Pharm. (London Stock Exchange): 0 recent articles
More Gw Pharmaceuticals News Articles